Tsuchihashi H, Yokoyama H, Nagatomo T
Department of Pharmacology, Niigata College of Pharmacy, Japan.
Jpn J Pharmacol. 1989 Jan;49(1):11-9. doi: 10.1254/jjp.49.11.
The present study was designed to examine the selectivity of 3H-CGP-12177 (4-(3-t-butylamino-2-hydroxypropoxy)-[5,7-3H]benzimidazole-2-one hydrochloride) for beta 1- and beta 2-adrenergic receptors by the Scatchard and the displacement analysis. The plots of specific binding obtained from the Scatchard analysis using 3H-CGP12177 for the rat myocardium membrane were uniphasic when the non-specific binding was determined by the use of 10 microM I-propranolol, and the Kd and Bmax values were 408.53 +/- 67.20 pM and 12.27 +/- 0.83 fmoles/mg protein, respectively. On the other hand, two binding sites were observed in the displacement curve when I-metoprolol was used as a competitor. The existence of these two binding sites implied the selectivity of 3H-CGP12177 to beta-adrenoceptors because 3H-CGP12177 was 1.8-fold more selective towards beta 1-adrenoceptors than beta 2-adrenoceptors. In addition, these two binding sites could be regarded as beta 1- and beta 2-adrenergic receptors from the evaluation of the binding characteristics beta-adrenoceptors by the displacement analysis using beta-selective antagonists. Thus, 3H-CGP12177, a hydrophilic radioligand, was useful for the binding assay of beta-adrenoceptors in rat myocardial membranes.
本研究旨在通过Scatchard法和置换分析来检测3H-CGP-12177(4-(3-叔丁氨基-2-羟基丙氧基)-[5,7-3H]苯并咪唑-2-酮盐酸盐)对β1和β2肾上腺素能受体的选择性。当使用10微摩尔异丙醇测定非特异性结合时,用3H-CGP12177对大鼠心肌膜进行Scatchard分析得到的特异性结合曲线为单相,Kd和Bmax值分别为408.53±67.20皮摩尔和12.27±0.83飞摩尔/毫克蛋白质。另一方面,当使用美托洛尔作为竞争剂时,在置换曲线中观察到两个结合位点。这两个结合位点的存在意味着3H-CGP12177对β肾上腺素能受体具有选择性,因为3H-CGP12177对β1肾上腺素能受体的选择性比对β2肾上腺素能受体高1.8倍。此外,通过使用β选择性拮抗剂的置换分析对β肾上腺素能受体的结合特性进行评估,这两个结合位点可被视为β1和β2肾上腺素能受体。因此,亲水性放射性配体3H-CGP12177可用于大鼠心肌膜中β肾上腺素能受体的结合测定。